Literature DB >> 28255790

[Contrast-enhanced ultrasound (CEUS) of the liver : Critical evaluation of use in clinical routine diagnostics].

K Müller-Peltzer1, J Rübenthaler2, M Reiser2, D-A Clevert2.   

Abstract

CLINICAL/METHODICAL ISSUE: Focal liver lesions are common incidental findings in abdominal ultrasound diagnostics. STANDARD RADIOLOGICAL
METHODS: Characterization of focal liver lesions solely based on b‑mode and color duplex is not feasible in all cases. METHODICAL INNOVATIONS: Using contrast-enhanced ultrasound (CEUS) it is possible to dynamically visualize the vascularization of focal liver lesions, which enables the characterization of benign and malignant liver tumors. The advantages of CEUS are that ultrasound contrast media do not show renal, hepatic or cardiac toxicity and do not influence the thyroid gland. The approach by fusion of CEUS and contrast-enhanced cross-sectional imaging combines the advantages of both imaging modalities. PERFORMANCE: Using CEUS focal liver lesions can be characterized with a diagnostic accuracy greater than 90%. ACHIEVEMENTS: The use of CEUS has become an important imaging modality to evaluate unclear liver lesions. PRACTICAL RECOMMENDATIONS: The use of CEUS provides vital information as a supplement to cross-sectional imaging and it has become an important tool in therapy planning, control and monitoring of malignant liver lesions.

Entities:  

Keywords:  Focal liver lesions; Fusion imaging; Hepatocellular carcinoma (HCC); Radiofrequency ablation (RFA); Transarterial chemoembolization (TACE)

Mesh:

Substances:

Year:  2017        PMID: 28255790     DOI: 10.1007/s00117-017-0225-z

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  25 in total

1.  The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations.

Authors:  Fabio Piscaglia; Luigi Bolondi
Journal:  Ultrasound Med Biol       Date:  2006-09       Impact factor: 2.998

2.  Potential value of contrast-enhanced intraoperative ultrasonography during partial hepatectomy for metastases: an essential investigation before resection?

Authors:  Edward Leen; Piercarlo Ceccotti; Susan J Moug; Paul Glen; John MacQuarrie; Wilson J Angerson; Thomas Albrecht; Joachim Hohmann; Anja Oldenburg; Jorg Peter Ritz; Paul G Horgan
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

3.  Ultrasound contrast agents as markers of vascularity and microcirculation.

Authors:  Christian Greis
Journal:  Clin Hemorheol Microcirc       Date:  2009       Impact factor: 2.375

4.  Vascular complications in liver transplantation: Beneficial role of contrast-enhanced ultrasound (CEUS) in the postoperative phase.

Authors:  J Rübenthaler; K J Paprottka; E Hameister; K Hoffmann; N Joiko; M Reiser; D A Clevert
Journal:  Clin Hemorheol Microcirc       Date:  2016       Impact factor: 2.375

Review 5.  Treatment algorithms for managing hepatocellular carcinoma.

Authors:  Vivek A Saraswat; Gaurav Pandey; Sachin Shetty
Journal:  J Clin Exp Hepatol       Date:  2014-06-06

6.  Dynamic evaluation and quantification of microvascularization during degradable starch microspheres transarterial Chemoembolisation (DSM-TACE) of HCC lesions using contrast enhanced ultrasound (CEUS): a feasibility study.

Authors:  P Wiggermann; W A Wohlgemuth; M Heibl; A Vasilj; M Loss; A G Schreyer; C Stroszczynski; E M Jung
Journal:  Clin Hemorheol Microcirc       Date:  2013       Impact factor: 2.375

7.  The role of contrast-enhanced sonography of focal liver lesions before percutaneous biopsy.

Authors:  Wei Wu; Min-Hua Chen; Shan-Shan Yin; Kun Yan; Zhi-Hui Fan; Wei Yang; Ying Dai; Ling Huo; Ji-You Li
Journal:  AJR Am J Roentgenol       Date:  2006-09       Impact factor: 3.959

Review 8.  Multimodal treatment of hepatocellular carcinoma (HCC).

Authors:  J W Sturm; M Keese
Journal:  Onkologie       Date:  2004-06

9.  Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial).

Authors:  D Strobel; K Seitz; W Blank; A Schuler; C Dietrich; A von Herbay; M Friedrich-Rust; G Kunze; D Becker; U Will; W Kratzer; F W Albert; C Pachmann; K Dirks; H Strunk; C Greis; T Bernatik
Journal:  Ultraschall Med       Date:  2008-10       Impact factor: 6.548

10.  Prevalence of benign focal liver lesions: ultrasound investigation of 45,319 hospital patients.

Authors:  Tanja Eva-Maria Kaltenbach; Phillip Engler; Wolfgang Kratzer; Suemeyra Oeztuerk; Thomas Seufferlein; Mark Martin Haenle; Tilmann Graeter
Journal:  Abdom Radiol (NY)       Date:  2016-01
View more
  3 in total

Review 1.  [Contrast-enhanced ultrasound (CEUS) and image fusion for procedures of liver interventions].

Authors:  E M Jung; D A Clevert
Journal:  Radiologe       Date:  2018-06       Impact factor: 0.635

2.  Diagnostic value of contrast-enhanced ultrasound versus computed tomography for hepatocellular carcinoma: a retrospective, single-center evaluation of 234 patients.

Authors:  Vincent Schwarze; Constantin Marschner; Wiebke Völckers; Sergio Grosu; Giovanna Negrão de Figueiredo; Johannes Rübenthaler; Dirk-André Clevert
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

3.  Clinical use of contrast-enhanced ultrasound beyond the liver: a focus on renal, splenic, and pancreatic applications.

Authors:  Giorgia Tedesco; Alessandro Sarno; Giulio Rizzo; Annamaria Grecchi; Ilaria Testa; Gabriele Giannotti; Mirko D'Onofrio
Journal:  Ultrasonography       Date:  2018-12-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.